2022
DOI: 10.1155/2022/4995196
|View full text |Cite
|
Sign up to set email alerts
|

Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors

Abstract: Background. Parathyroid tumors are common endocrine neoplasias associated with primary hyperparathyroidism. Although numerous studies have studied the subject, the predictive value of gene biomarkers nevertheless remains low. Methods. In this study, we performed genomic analysis of abnormal DNA methylation in parathyroid tumors. After data preprocessing, differentially methylated genes were extracted from patients with parathyroid tumors by using t-tests. Results. After refinement of the basic differential met… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 67 publications
0
1
0
Order By: Relevance
“…Other studies have found that miRNAs like miR-222 [13], miR-503 [13] , and miR-517c [14] are significantly upregulated in parathyroid carcinoma. Bioinformatics has also been used to identify key genes and molecular pathways in parathyroid neoplasms [15], and thyroid cancer microarray profiles have been examined to investigate differential gene expression and pathway enrichment [16] . Mehrdad Ameri et al successfully used bioinformatics methods to screen biomarkers for follicular thyroid carcinoma (FTC) and FTA.…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…Other studies have found that miRNAs like miR-222 [13], miR-503 [13] , and miR-517c [14] are significantly upregulated in parathyroid carcinoma. Bioinformatics has also been used to identify key genes and molecular pathways in parathyroid neoplasms [15], and thyroid cancer microarray profiles have been examined to investigate differential gene expression and pathway enrichment [16] . Mehrdad Ameri et al successfully used bioinformatics methods to screen biomarkers for follicular thyroid carcinoma (FTC) and FTA.…”
Section: Accepted Manuscriptmentioning
confidence: 99%